FDA Says Benefits Outweigh Risks for Kids’ COVID-19 Vaccine

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The FDA has reviewed the clinical trial data on Pfizer’s vaccine for children and concluded that the benefits of the 2-shot series outweigh its risks for kids. In a briefing document posted to the FDA website late Friday, agency scientists said that they had used the […]
Continue reading »